Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Tg Therapeuticscmn (NASDAQ: TGTX)

$11.65 USD $0.25 (2.19%)
Last Price $11.65
Net Change $0.25 (2.19%)
Bid $11.15
Ask Price $11.75
Open Price $11.15
Previous Close Price $11.4
High Price $11.7
Low Price $10.95
Number of Trades 4,948
Volume 1,247,516
Fifty Two Week High $15.05 (2017-03-16)
Fifty Two Week Low $4.1 (2017-01-24)
Average Daily Volume 2,059,488
Share Outstanding 56,910 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $2.34
Recent Earnings $
Annual EPS $-1.5
Last Quarter EPS $
Market Capitalization $0.66B
Insider Shareholders % 0.19%
Annual Revenue $0B
No. Shares Outstanding 56,910
Inst. Shareholder % 36.24%
Annual Net Income $-0.08B
TTM Net Profit Margin $-48906.25
1-Year Return 38.18%
3-Year Return 77.29%
5-Year Return 56.59%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 2.34%
Dividends per Share $
Stock Split Ratio 1-56
Beta 1.08
TG Therapeutics Inc. is a biopharmaceutical company focused on the acquisition development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma leukemia and auto-immune diseases. TG Therapeutics Inc. formerly known as Manhattan Pharmaceuticals Inc. is based in New York.